Neuroendocrinology News

A statement released by the Pituitary Society outlines criteria for developing pituitary tumor centers of excellence and asserts that the best care for patients comes from a collaboration of endocrinologists and experienced pituitary surgeons.

Patients treated with immune checkpoint inhibitors, including CTLA-4 and PD-1 inhibitors, are at an increased risk for developing endocrine immune-related adverse events, particularly thyroid dysfunction, according to research reported in Clinical Endocrinology.

Crinetics Pharmaceuticals, a company that focuses on therapeutics for endocrine disorders and related cancers, has received two new grants from the National Institute of Diabetes and Digestive and Kidney Diseases of the NIH, according to a company press release.

The incidence of myocardial infarction and stroke among patients with acromegaly is similar to that of the general population, and researchers observed no relationship between stroke and radiation therapy, according to findings published in Pituitary.

Takotsubo-like catecholamine cardiomyopathy occurred in nearly 3% of patients with secreting pheochromocytoma and paraganglioma, researchers in Canada reported.

In healthy women, the regions of the brain associated with reward, behavior and emotions responded differently to visual food cues during the luteal phase vs. the follicular phase of the menstrual cycle, according to a study using functional MRI.

The risk for recurrence or progression of pituitary neuroendocrine tumors in adults is significantly associated with age and tumor type, according to findings published in The Journal of Clinical Endocrinology & Metabolism.

Secondary adrenal insufficiency was linked to changes to the cortisol secretion rate and adrenocorticotropic hormone, or ACTH, dose-response curve, according to findings published in Journal of the Endocrine Society.

The need for secondary treatment in adults with surgically resected nonfunctioning pituitary adenomas may be predicted by the presence of residual tumor, growth rate and location, according to findings published in Clinical Endocrinology.

In a study published in the Journal of Clinical Endocrinology and Metabolism, researchers from Denmark reported lifelong low BMI was not linked with an increased risk for Alzheimer’s disease.